Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

With state-of-the-art facilities and internationally renowned researchers, we are pioneering technologies to improve the diagnosis and monitoring of cancer, and to guide new forms of precision ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR. Women with an aggressive form of breast cancer who have faults in ...

Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes ...

Professor Johann de Bono is Regius Professor of Cancer Research and a Professor in Experimental Cancer Medicine at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. He is ...